Literature DB >> 19324912

Time courses of subcellular signal transduction and cellular apoptosis in remote viable myocardium of rat left ventricles following acute myocardial infarction: role of pharmacomodulation.

Sarah Chua1, Li-Teh Chang, Cheuk-Kwan Sun, Jiunn-Jye Sheu, Fan-Yen Lee, Ali A Youssef, Cheng-Hsu Yang, Chiung-Jen Wu, Hon-Kan Yip.   

Abstract

We tested hypothesis that acute myocardial infarction (AMI) induces cellular apoptosis and serial changes of protein kinase C epsilon (PKC-epsilon) and p38 mitogen-activated protein kinase (p38 MAPK), and tested cardio-protective effect of losartan in this condition. The rats were assigned to group A (sacrificed on day 2), group B (sacrificed on day 5), and group C (sacrificed on day 14). Rats in each group were further randomized into the following groups: AMI (ligation of left coronary artery) without losartan (AMI-L0); AMI with losartan 20 mg/ kg/d (AMI-L1); and sham groups (L0 and L1). The PKC-epsilon expression in membrane compartment was increased in AMI-L1 group than in other groups on day 5 and in AMI groups than in sham groups on day 14 (P < .01). Phosphorylated form of cytosolic p38 MAPK level was increased in AMI-L1 than in other groups on day 14 (P < .05). Furthermore, 14-day left ventricular ejection fraction was higher and cellular apoptosis was lower in AMI-L1 group than in AMI-L0 group (P < .0001).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324912     DOI: 10.1177/1074248409332841

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  4 in total

1.  SS31 therapy effectively protects the heart against transverse aortic constriction-induced hypertrophic cardiomyopathy damage.

Authors:  Hung-I Lu; Fan-Yen Lee; Christopher Glenn Wallace; Pei-Hsun Sung; Kuan-Hung Chen; Jiunn-Jye Sheu; Sarah Chua; Meng-Shen Tong; Tien-Hung Huang; Yi-Ling Chen; Pei-Lin Shao; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Entresto therapy effectively protects heart and lung against transverse aortic constriction induced cardiopulmonary syndrome injury in rat.

Authors:  Hung-I Lu; Meng-Shen Tong; Kuan-Hung Chen; Fan-Yen Lee; John Y Chiang; Sheng-Ying Chung; Pei-Hsun Sung; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.

Authors:  Chih-Chao Yang; Hon-Kan Yip; Kuan-Hung Chen; Cheuk-Kwan Sun; Yen-Ta Chen; Han-Tan Chai; Pei-Hsun Sung; Hsin-Ju Chiang; Sheung-Fat Ko; Sheng-Ying Chung; Chih-Hung Chen; Kun-Chen Lin; Pao-Yuan Lin; Jiunn-Jye Sheu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia.

Authors:  Tyesha N Burks; Eva Andres-Mateos; Ruth Marx; Rebeca Mejias; Christel Van Erp; Jessica L Simmers; Jeremy D Walston; Christopher W Ward; Ronald D Cohn
Journal:  Sci Transl Med       Date:  2011-05-11       Impact factor: 17.956

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.